Clinical Trials Directory

Trials / Completed

CompletedNCT01669291

Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation

Effect of GnRH Antagonist Protocol vs Agonist Long Protocol During Controlled Hyperstimulation (COH)for Assisted Reproduction on IVF Outcome, Peak Estradiol Level, and Duration of Stimulation.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Main Line Fertility Center · Academic / Other
Sex
Female
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if utilizing GnRH antagonists versus agonist long protocol during controlled ovarian stimulation (COH) with human-derived gonadotropins for assisted reproduction affects IVF outcome, peak estradiol level, and duration of stimulation.

Detailed description

No detailed description

Conditions

Interventions

TypeNameDescription
DRUGBravelle and MenopurBravelle and Menopur are used for controlled ovarian stimulation (COH)
DRUGAgonistAgonist (Lupron) is used to suppress endogenous pituitary LH for the premature LH surges.
DRUGAntagonistGanirelix acetate or cetrorelix acetate Agonist is used to suppress endogenous pituitary LH for the premature LH surges.

Timeline

Start date
2012-07-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2012-08-21
Last updated
2014-06-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01669291. Inclusion in this directory is not an endorsement.